期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Research in Chinese Medicine. 2026; 6: (1) ; 47-50 ; DOI: 10.12208/j.ircm.20260011.

Basic research on traditional Chinese medicine treatment and in vitro prevention of schistosomiasis
血吸虫病中医治疗与体外预防的基础研究

作者: 贺宏州 *

荆州市第三人民医院 湖北荆州

*通讯作者: 贺宏州,单位:荆州市第三人民医院 湖北荆州 ;

发布时间: 2026-03-11 总浏览量: 89

摘要

目的 探究血吸虫病患者采用中药内服与中药方剂体外治疗的临床效果。方法 本研究纳入本院2023年4月-2025年4月收治血吸虫病患者,共入组86例。依照数字随机表法划分2个小组,对照组(n=43)采用常规西医治疗,观察组(n=43)在此基础上采用中药内服与自拟中药方剂(辟蛊汤)体外治疗。根据症状改善情况、临床治疗效果、不良反应评价2组治疗情况。结果 对比症状改善指标(腹痛消退时间、发热消退时间、黏液血便消退时间),观察组相较对照组均明显缩短,组间有统计学差异(P<0.05)。对比临床疗效评估情况,观察组总有效率相较对照组明显提高,组间有统计学差异(P<0.05)。对比不良反应情况,对照组、观察组患者无统计学差异(P>0.05)。结论 血吸虫病患者采用中药内服与中药方剂体外治疗能进一步提升治疗效果,加快症状消退,且安全性较好。

关键词: 血吸虫病;中医方剂;不良反应

Abstract

Objective To explore the clinical effects of oral administration of traditional Chinese medicine and external treatment with traditional Chinese medicine prescriptions for patients with schistosomiasis.
Methods This study included patients with schistosomiasis admitted to our hospital from April 2023 to April 2025, with a total of 86 cases enrolled. Two groups were divided according to the digital random table method. The control group (n=43) was treated with conventional Western medicine, while the observation group (n=43) was treated with internal administration of traditional Chinese medicine and external treatment with a self-designed traditional Chinese medicine prescription (Bi Gu Decoction) on this basis. The treatment conditions of the two groups were evaluated based on the improvement of symptoms, clinical treatment effects and adverse reactions.
Results Compared with the symptom improvement indicators (the time for abdominal pain to subside, the time for fever to subside, and the time for mucus and bloody stool to subside), the observation group was significantly shorter than the control group, and there was a statistically significant difference between the groups (P < 0.05). By comparing the clinical efficacy assessment, the total effective rate of the observation group was significantly higher than that of the control group, and there was a statistically significant difference between the groups (P < 0.05). When comparing the adverse reactions, there was no statistically significant difference between the control group and the observation group (P > 0.05).
Conclusion   For patients with schistosomiasis, internal administration of traditional Chinese medicine and external treatment with traditional Chinese medicine prescriptions can further enhance the therapeutic effect, accelerate the resolution of symptoms, and have good safety.

Key words: Schistosomiasis; Traditional chinese medicine prescriptions; Adverse reactions

参考文献 References

[1] 蒲晨,张宇,万佳嘉,等. 2015-2023年四川省血吸虫病综合防治效果[J]. 中国血吸虫病防治杂志,2025,37(3): 284-288. 

[2] 魏素芳. 多次吡喹酮治疗血吸虫病的临床效果及安全性观察[J]. 基层医学论坛,2023,27(32):40-42. 

[3] 于鹏,王沁,汪饶春,等. 膈下逐瘀汤治疗晚期血吸虫病肝纤维化临床观察[J]. 中国中医药现代远程教育,2024, 22(12):53-56. 

[4] 赵训智,周晓蓉. 苓术二泽汤加减治疗血吸虫性肝硬化合并顽固性腹水临床疗效观察[J]. 热带医学杂志,2024, 24(10):1400-1403. 

[5] 谢伟,杨朝敏. 养血柔肝汤治疗晚期血吸虫病的疗效[J]. 黑龙江中医药,2023,52(6):186-188. 

[6] 何洋,王丽君. 桃仁四物汤加减联合西药治疗血吸虫性肝硬化的临床效果及对肝功能的影响[J]. 临床合理用药杂志,2022,15(2):96-98. 

[7] 罗军涛,钱胜南,吴凯悦,等. 探讨青蒿琥酯和扶正化瘀方治疗血吸虫病肝纤维化对线粒体的影响[J]. 中华肝脏病杂志,2022,30(1):45-51.  

[8] 王晓娟. 中西药合用治疗慢性血吸虫病合并慢性结肠炎的临床研究[J]. 基层医学论坛,2023,27(17):118-120, 150.

[9] 万军茂. 舒肝宁注射液配合常规西药治疗晚期血吸虫病肝纤维化的临床疗效及安全性分析[J]. 实用中西医结合临床,2023,23(17):47-49,63. 

[10] 郑娜,段娟,彭妮娜,等. 清肝冲剂与吡喹酮联用治疗晚期血吸虫病患者效果观察[J]. 热带医学杂志,2023,23(9): 1241-1245.

引用本文

贺宏州, 血吸虫病中医治疗与体外预防的基础研究[J]. 国际中医药研究, 2026; 6: (1) : 47-50.